Use of single-dose nevirapine for the prevention of mother-to-child transmission of HIV-1: does development of resistance matter?

This publication has 38 references indexed in Scilit:

• Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa?
  AIDS, 2005
• REVIEW: Preventing mother‐to‐child transmission of HIV: successes and challenges
  BJOG: An International Journal of Obstetrics and Gynaecology, 2005
• Is “3 by 5” enough? Recalculating the global need for antiretroviral treatment
  The Lancet, 2004
• Single-Dose Perinatal Nevirapine plus Standard Zidovudine to Prevent Mother-to-Child Transmission of HIV-1 in Thailand
  New England Journal of Medicine, 2004
• Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial
  The Lancet, 2003
• Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial
  The Lancet, 2002
• Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)
  AIDS, 2001
• Prevention of Mother-to-Child HIV Transmission in Resource-Poor Countries
  JAMA, 2000
• Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
  The Lancet, 1999
• Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
  New England Journal of Medicine, 1994